Company profile for KSQ Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

KSQ Therapeutics, we seek to understand the role of every human gene in each disease, each tissue, and each cell that we study. This comprehensive approach has resulted in a massive, experimentally derived dataset that we have found to be remarkably predictive of past successes and failures in oncology and immuno-oncology product development. Utilizing this approach, we also identified a number of opportunities for the develop...
KSQ Therapeutics, we seek to understand the role of every human gene in each disease, each tissue, and each cell that we study. This comprehensive approach has resulted in a massive, experimentally derived dataset that we have found to be remarkably predictive of past successes and failures in oncology and immuno-oncology product development. Utilizing this approach, we also identified a number of opportunities for the development of new medicines.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
610 Main Street North 4th Floor Cambridge MA, 02139
Telephone
Telephone
+617-674-9150
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/09/3058270/0/en/KSQ-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-2-Study-for-KSQ-004EX-a-CRISPR-Cas9-Engineered-Tumor-Infiltrating-Lymphocyte-eTIL-Therapy.html

GLOBENEWSWIRE
09 Apr 2025

https://www.globenewswire.com/news-release/2025/03/05/3037288/0/en/KSQ-Therapeutics-Appoints-Kristen-Hege-M-D-to-its-Board-of-Directors.html

GLOBENEWSWIRE
05 Mar 2025

https://www.globenewswire.com/news-release/2024/10/22/2966785/0/en/KSQ-Therapeutics-Appoints-John-Lepore-M-D-to-its-Board-of-Directors.html

GLOBENEWSWIRE
22 Oct 2024

https://www.globenewswire.com/en/news-release/2024/10/08/2959551/0/en/KSQ-Therapeutics-Appoints-Anna-Truppel-Hartmann-M-D-as-Chief-Medical-Officer.html

GLOBENEWSWIRE
08 Oct 2024

https://www.globenewswire.com/news-release/2024/09/24/2952011/0/en/KSQ-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-KSQ-004EX-a-CRISPR-Cas9-Engineered-Tumor-Infiltrating-Lymphocyte-eTIL-Therapy.html

GLOBENEWSWIRE
24 Sep 2024

https://www.globenewswire.com/news-release/2024/08/28/2936872/0/en/KSQ-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
28 Aug 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty